1195 Comparison of Pseudocapsule Dissection Techniques on Remission and Recurrence in Cushing’s Disease: A Retrospective Cohort Study

View at publisher Summarise with VIRAT
Authors: Jared H. Chung, Georgios A. Maragkos, Georgios Mantziaris, Michael Paul Catalino, Gregory K. Hong, Erica Alexandra Giraldi, YAMINI R. STERRETT, John A. Jane
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Transsphenoidal resection (TSR) remains the primary treatment for Cushing’s disease. Prior studies have suggested that exploiting the tumor pseudocapsule—a fibrous boundary between adenoma and normal pituitary—may enhance surgical precision and reduce recurrence. METHODS: We retrospectively reviewed 102 Cushing’s disease patients who underwent TSR. Patients with MRI-negative lesions (n = 10) or prophylactic radiosurgery following biochemical remission (n = 12) were excluded, resulting in 80 patients for analysis. Tumors were considered to have six walls: anterior, posterior, superior, inferior, medial, and lateral. Patients were grouped by pseudocapsular dissection extent, determined by the number of walls dissected. Clinical, radiographic, and intraoperative data were extracted. Primary outcome was recurrence-free survival (RFS), assessed via Kaplan-Meier analysis. Tumor size was considered as a factor influencing pseudocapsular dissection; however, multivariable Cox regression was not performed due to lack of recurrence in groups A and C. Secondary outcome was surgery-only remission, defined as biochemical remission without adjuvant therapy, evaluated using logistic regression. RESULTS: Surgery-only remission was achieved in 82.5% of patients. Maximum preoperative tumor diameter was significantly associated with pseudocapsular dissection extent (p = 0.0101), with larger tumors more likely to undergo complete or near-total dissection. In logistic regression, Group A (OR = 9.70, p = .006) had significantly higher odds of achieving surgery-only remission compared to Group B. Groups B (OR = 0.38, p = .050) and C (OR = 0.39, p = .30) had lower remission. Groups A (complete/near-total/majority-dissected pseudocapsule) and C (subtotal hypophysectomy) had no recurrence over mean (SD) 48.9 ± 28 and 50.7 ± 15 months, respectively. Group B (partial pseudocapsule/piecemeal dissection) demonstrated 7 recurrences over mean (SD) 48.9 ± 19 months. CONCLUSIONS: Pseudocapsular dissection extent is a strong predictor of surgery-only remission and recurrence-free survival in patients undergoing TSR for Cushing’s disease. Achieving more intact pseudocapsular dissection is associated with improved long-term outcomes, supporting a more meticulous pseudocapsule-based TSR when feasible.

Fields of Study & Subjects

Pituitary Gland Disorders and Treatments Meningioma and schwannoma management Adrenal and Paraganglionic Tumors

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
233–233
Publication date
26 March 2026
Language
EN